| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.06 | 0.3 |